Transmitted HIV‐1 drug resistance in a large international cohort using next‐generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study is a research paper published in HIV Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: UM1‐AI068641
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: UM1‐AI120197
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: 1U01‐AI36780
NIAID NIH HHS
Grant: U01 AI136780
NIAID NIH HHS
Grant: UM1 AI120197
NIAID NIH HHS
Grant: UM1 AI068641
National Institutes of Health
Grant: 5UM1AI068641-09
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
National Institutes of Health
Grant: 1UM1AI120197-01
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals